PsychiatryNews.net

Psychiatry Xagena

The reported risk of depression in patients with hypomagnesaemia is controversial. The objective of a meta-analysis was to assess the association between depression and hypomagnesaemia. Six obse ...


Placebo-controlled trials indicate that Cytisine, a partial agonist that binds the nicotinic acetylcholine receptor and is used for smoking cessation, almost doubles the chances of quitting at 6 month ...


Antipsychotics and mood stabilisers are prescribed widely to patients with psychiatric disorders worldwide. Despite clear evidence for their efficacy in relapse prevention and symptom relief, their ef ...


Few pharmacotherapies have demonstrated sufficient efficacy in the treatment of posttraumatic stress disorder ( PTSD ), a chronic and disabling condition. A study has evaluated the efficacy and saf ...


Depressive symptoms are common in schizophrenia and can worsen outcomes and increase suicide risk. Lurasidone ( latuda ) is an atypical antipsychotic agent indicated for the treatment of schizophrenia ...


Treatment of bipolar depression is complicated by variable response and risk of switch to mania. Guidance is informed by the strength of evidence rather than by comparative data. Researchers have p ...


Since the 1970s, clinicians have increasingly become more familiar with hyperprolactinemia ( HPRL ) as a common adverse effect of antipsychotic medication, which remains the cornerstone of pharmacolog ...


Since 1999, there has been a dramatic increase in opioid overdose deaths and addiction to opioid drugs, including both prescription opioid pain relievers and heroin. Increased rates of addiction hav ...


A study has determined, using research on Duloxetine ( Cymbalta ) for major depressive disorder as an example, if there are inconsistencies between protocols, clinical study reports, and main publicly ...


A study has investigated if the widely publicized warnings in 2003 from the FDA ( Food and Drug Administration ) about a possible increased risk of suicidality with antidepressant use in young people ...


In Sweden, a study has investigated the association between drug treatment for attention-deficit / hyperactivity disorder ( ADHD ) and risk of concomitant suicidal behaviour among patients with ADHD. ...


A systematic review and meta-analysis of observational studies has investigated the change in mental health after smoking cessation compared with continuing to smoke. Eligibility criteria were long ...


A systematic review and meta-analysis was performed on published and unpublished efficacy studies of Agomelatine in people with depression. The eligibility criteria were double blind randomised pla ...


Combining pharmacotherapies for tobacco-dependence treatment may increase smoking abstinence. A study has determined efficacy and safety of Varenicline and Bupropion sustained-release ( SR; combinatio ...


A review on the efficacy and the tolerability of Quetiapine ( Seroquel ), either as monotherapy or combination therapy, for acute bipolar depression, was done. Researchers have included all randomi ...


Ketamine's efficacy in depressive disorders has been established in several controlled trials. The aim of a study was to determine whether or not Ketamine administration significantly improves depress ...


The purpose of a study was to determine whether stimulant users are at higher risk of a later cardiovascular event than are non-users, examining this association in both a national cohort and a popula ...


Psychotherapy is the treatment of choice for patients with anorexia nervosa, although evidence of efficacy is weak. The Anorexia Nervosa Treatment of OutPatients ( ANTOP ) study aimed to assess the ef ...


Health anxiety has been treated by therapists expert in cognitive behaviour therapy with some specific benefit in some patients referred to psychological services. Those in hospital care have been les ...


The aim of a study was to determine the prevalence of drug-induced long QT at admission to a public psychiatric hospital and to document the associated factors using a cross-sectional approach. All ...


In 2009, the FDA ( Food and Drug Administration ) issued a black box warning for Varenicline ( Champix; in Europe: Champix ) regarding neuropsychiatric events. Researchers used data from randomized c ...


Anorexia nervosa is characterised by a chronic course that is refractory to treatment in many patients and has one of the highest mortality rates of any psychiatric disorder. Deep brain stimulation ( ...


Delirium is frequently diagnosed in critically ill patients and is associated with poor clinical outcomes. Haloperidol ( Haldol, Serenase ) is the most commonly used drug for delirium despite little e ...


A study has prospectively evaluated consumptions of sweetened beverages, coffee and tea in relation to depression among older US adults. Sweetened beverages, coffee and tea are commonly consumed world ...


Risperidone ( Risperdal ) is an atypical antipsychotic agent indicated for the treatment or management of schizophrenia, inappropriate behaviour associated with severe dementia and manic episodes asso ...


Clinicians have long speculated that poor sleep may be a mechanism involved in the higher risk of further cardiac events or death among those with post-traumatic stress disorder ( PTSD ) following an ...


Hyponatremia ( serum sodium concentration [ Na+ ] less than 136 mEq/L ) is a potentially life-threatening condition often found chronically in patients with psychotic disorders. Vasopressin antagoni ...


Excess weight and obesity in the general population are increasing problems throughout the Western world, and this rise has also been observed in children and adolescents.Weight gain and obesity are k ...


Varenicline ( Chantix, Champix ), a smoking cessation medication, has been under a cloud of suspicion ever since the Canadian Medical Association Journal ( CMAJ ) published a study July 2011 reporting ...


New data have shown the efficacy of Agomelatine ( Valdoxan ) in the treatment of anxiety in depressed patients when compared with other commonly prescribed antidepressants. Additionally, Valdoxan's an ...


The poor safety profile of the smoking-cessation drug Varenicline ( Chantix, Champix ) makes it unsuitable for first-line use, according to a study published in the journal PLoS One,Varenicline, which ...


Taking newer types of antipsychotic drugs could increase a person’s risk of developing dangerous blood clots, according to a new University of Nottingham study published on British Medical Journal.Ven ...


A pilot study has suggested the hallucinogen Psilocybin may be feasible and safe to administer to patients with advanced-stage cancer and anxiety, with promising effects on mood.In recent years, there ...


Naltrexone, a drug commonly used to treat alcohol and drug addiction, has a similar effect on the compulsive behavior of kleptomaniacs; it curbs their urge to steal.Kleptomania is a type of impulse co ...


Asenapine ( Saphris ) met the primary endpoint over one year of treatment in an extension study in patients with predominant, persistent negative symptoms of schizophrenia.Negative symptoms of schizop ...


Bipolar disorder appears to increase the risk of early death from medical illnesses, according to a literature review study published in the journal Psychiatric Services.The researchers comprehensivel ...


Saphris ( Asenapine ) is a psychotropic agent indicated for acute treatment of schizophrenia in adults and acute treatment of manic or mixed episodes associated with bipolar I disorder with or without ...


About 44% of individuals who had bipolar disorder as children continue to have manic episodes as young adults.Recent data has demonstrated an enormous increase in the diagnosis of pediatric bipolar di ...


Nearly every child who receives an antipsychotic drug is first prescribed one of the second-generation, or atypical drugs, such as Olanzapine ( Zyprexa ) and Risperidone ( Risperdal ). However, there ...


Second-generation antipsychotic drugs are not necessarily better than the first-generation drug Haloperidol ( Haldol ) at treating a first episode of schizophrenia.Second-generation drugs, introduced ...


Second-generation antipsychotic drugs are not necessarily better than the first-generation drug Haloperidol ( Haldol ) at treating a first episode of schizophrenia.Second-generation drugs, introduced ...


Two randomised, double-blind, placebo-controlled studies assessed the efficacy of Quetiapine extended release ( Seroquel XR ) in patients with bipolar disorder: the first ( Study 002 ) examined acute ...


Taking the antidepressant Citalopram ( Celexa, Seropram ) before beginning treatment for head and neck cancer may help prevent depression during therapy, according to results of a pilot study. Trea ...


New research provides support for the use of St.John's wort extracts in treating major depression. A Cochrane Systematic Review backs up previous research that showed the plant extract is effective in ...


A research has shown that selective serotonin reuptake inhibitors ( SSRIs ), a group of drugs commonly used to treat depression, may double the risk of gastrointestinal bleeding. When the drugs are ta ...


Specific variations in two genes are linked to suicidal thinking that sometimes occurs in people taking the most commonly prescribed class of antidepressants, according to a large study led by scienti ...


Researchers have found surprising evidence that an antidepressant, Citalopram ( Celexa, Seropram ), may perform as well as a commonly-prescribed antipsychotic, Risperidone ( Risperdal ), in the allevi ...


Studies with rats have revealed the potential in an entirely new class of antidepressants that take effect after only days of treatment versus the weeks required for current drugs. Depression can b ...


Adults with attention-deficit / hyperactivity disorder ( ADHD ) show a blunted response to the Methylphenidate ( Ritalin ), which increases brain dopamine levels. This suggests that dopamine dysfunct ...


Daily use of the antidepressant medications known as selective serotonin reuptake inhibitors ( SSRIs ) by adults 50 years and older is associated with a doubled risk of some fractures. Depression a ...



2000-2014© XAGENA srl - P.IVA: 04454930969 - REA: 1748680 - Tutti i diritti riservati